CSTONE PHARMACEUTICALS earnings per share and revenue

2616 earnings per share for the last semiannual are 0.01 HKD whereas the estimation was -0.11 HKD which accounts for 110.00% surprise. Company revenue for the same period amounts to 273.08 M HKD despite the estimated figure of 331.93 M HKD. Estimated earnings per share for the next semiannual are -0.03 HKD, and revenue is expected to reach 340.74 M HKD. Also watch annual changes over time to get a bigger picture of 2616 earnings per share and revenue dynamics.